{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:55:30Z","timestamp":1760234130425,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T00:00:00Z","timestamp":1618704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Pediatric inflammatory multisystem syndrome temporally associated with SARS Cov2 (PIMS-TS) is a newly encountered disease in children sharing clinical features with Kawasaki disease, toxic shock syndrome, or macrophage-activating syndrome. Pathogenically, it is associated with immune-mediated post-infectious hyperinflammation leading to short-term myocardial injury with yet unknown long-term outcome. We herein present three cases of PIMS-TS treated in our institution with divided doses of immunoglobulins and high dose acetyl salicylic acid, according to existing Kawasaki disease guidelines. Due to greater weight in adolescents affected and concerns of rheological sequelae following possible hyperviscosity, doses of immunoglobulins were divided and given 24 h apart with good tolerability. All patients recovered rapidly with normalization of previously encountered cardiac manifestations. As diagnosis of PIMS-TS should be made promptly, timing of therapy is of paramount importance for a favorable outcome. To date, no randomized controlled trial data exist concerning treatment recommendations. 1.8% (95% CI: 1.7% to 2.0%) of all children and adolescents in the county district of Ostallg\u00e4u were tested positive for SARS CoV-2, incidence of PIMS-TS was 1.7% (95% CI: 0.9% to 3.1%) among SARS CoV-2 positive tested earlier. As the pandemic is still ongoing, rising numbers of PIMS-TS in children might be expected.<\/jats:p>","DOI":"10.3390\/healthcare9040481","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T22:15:13Z","timestamp":1618784113000},"page":"481","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS) with Split Doses of Immunoglobulin G and Estimation of PIMS-TS Incidence in a County District in Southern Germany"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-924X","authenticated-orcid":false,"given":"G\u00f6tz","family":"Wehl","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hospital Ostallg\u00e4u-Kaufbeuren, 87600 Kaufbeuren, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Franke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Ostallg\u00e4u-Kaufbeuren, 87600 Kaufbeuren, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fr\u00fchwirth","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital St. Vinzenz, 6511 Zams, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Edlinger","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Informatics, and Health Economics, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Rauchenzauner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Ostallg\u00e4u-Kaufbeuren, 87600 Kaufbeuren, Germany"},{"name":"Department of Pediatrics, Hospital St. Vinzenz, 6511 Zams, Austria"},{"name":"Department of Pediatrics, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: Prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S1473-3099(20)30651-4","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents","volume":"20","author":"Jiang","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"ref_5","unstructured":"WHO (2020). Multisystem Inflammatory Syndrome in Children and Adolscents Temporally Related to COVID-19 [Scientific Brief], World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1097\/INF.0000000000002801","article-title":"PIMS-TS and Kawasaki Disease: The Mystery Deepens","volume":"39","author":"Lutchman","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S2352-4642(20)30215-7","article-title":"Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: A multicentre observational study","volume":"4","author":"Davies","year":"2020","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse Effects of Intravenous Immunoglobulin Therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf."},{"key":"ref_9","unstructured":"Altman, D.G., Machin, D., Bryant, T.N., and Gardner, M.J. (2000). Statistics with Confidence; Confidence Intervals and Statistical Guidelines, BMJ Books. [2 ed.]."},{"key":"ref_10","unstructured":"Becker, T., and Greif, C. Personal communication."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8878946","article-title":"Varying Presentations of Multisystem Inflammatory Syndrome Temporarily Associated with COVID-19","volume":"2020","author":"Krikilion","year":"2020","journal-title":"Case Rep. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e20201711","DOI":"10.1542\/peds.2020-1711","article-title":"SARS-CoV-2\u2013Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children","volume":"146","author":"Licciardi","year":"2020","journal-title":"Pediatrics"},{"key":"ref_13","first-page":"1901","article-title":"High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more","volume":"179","author":"Suzuki","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_15","unstructured":"DGPI (2021, March 09). PIMS Falldefinition. Available online: www.dgpi.de\/pims-survey-anleitung."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Felsenstein, S., Willis, E., Lythgoe, H., McCann, L., Cleary, A., Mahmood, K., Porter, D., Jones, J., McDonagh, J., and Chieng, A. (2020). Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS). J. Clin. Med., 9.","DOI":"10.3390\/jcm9103293"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Radia, T., Williams, N., Agrawal, P., Harman, K., Weale, J., Cook, J., and Gupta, A. (2020). Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr. Respir. Rev.","DOI":"10.1016\/j.prrv.2020.08.001"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"626182","DOI":"10.3389\/fped.2020.626182","article-title":"Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis\u2014A Critical Review of Its Pathogenesis and Treatment","volume":"8","author":"McMurray","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.paed.2020.12.003","article-title":"SARS-CoV-2 paediatric inflammatory syndrome","volume":"31","author":"Evans","year":"2021","journal-title":"Paediatr. Child Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s13312-020-1901-z","article-title":"Hyper-inflammatory Syndrome in a Child with COVID-19 Treated Successfully with Intravenous Immunoglobulin and Tocilizumab","volume":"57","author":"Balasubramanian","year":"2020","journal-title":"Indian Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS\u2013CoV-2","volume":"130","author":"Diorio","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_22","first-page":"307","article-title":"Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: A comprehensive review and proposed clinical approach","volume":"180","author":"Sperotto","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/4\/481\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:49:24Z","timestamp":1760161764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/4\/481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,18]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["healthcare9040481"],"URL":"https:\/\/doi.org\/10.3390\/healthcare9040481","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2021,4,18]]}}}